KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Shares Outstanding (2016 - 2026)

Medtronic (MDT) has disclosed Shares Outstanding for 14 consecutive years, with $1.3 billion as the latest value for Q1 2026.

  • Quarterly Shares Outstanding changed 0.03% to $1.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Jan 2026, changed 0.03% year-over-year, with the annual reading at $1.3 billion for FY2025, 2.22% down from the prior year.
  • Shares Outstanding hit $1.3 billion in Q1 2026 for Medtronic, roughly flat from $1.3 billion in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $1.3 billion in Q1 2022 to a low of $1.3 billion in Q2 2025.
  • Historically, Shares Outstanding has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2022.
  • Biggest five-year swings in Shares Outstanding: grew 0.08% in 2023 and later dropped 3.61% in 2024.
  • Year by year, Shares Outstanding stood at $1.3 billion in 2022, then changed by 0.0% to $1.3 billion in 2023, then dropped by 3.53% to $1.3 billion in 2024, then fell by 0.08% to $1.3 billion in 2025, then increased by 0.11% to $1.3 billion in 2026.
  • Business Quant data shows Shares Outstanding for MDT at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.